Jane Street’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Buy
53,952
+21,833
+68% +$93.9K ﹤0.01% 9911
2026
Q2
$82.2K Buy
+32,119
New +$63.6K ﹤0.01% 10707
2026
Q1
– Sell
-4,874
Closed -$26.8K – 11422
2025
Q4
$26.8K Buy
4,874
+4,380
+887% +$35.5K ﹤0.01% 10667
2025
Q3
$4.36K Sell
494
-500
-50% -$4.87K ﹤0.01% 10613
2025
Q2
$7.51K Buy
+994
New +$15K ﹤0.01% 9417
2022
Q3
– Sell
-22
Closed -$19K – 9608
2022
Q2
$19K Buy
+22
New +$19.9K ﹤0.01% 9171
2019
Q2
– Sell
-49
Closed -$105K – 5060
2019
Q1
$105K Buy
+49
New +$146K ﹤0.01% 4767

Other funds holding AZR

Jane Street's AZR Position: Q3 2026 in Review

Jane Street increased its Azora Therapeutics, Inc. Common Stock (AZR) stake by 68% in Q3 2026, buying an estimated $93.9K and bringing the position to 53,952 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #9911.

Jane Street first reported a position in AZR in Q1 2019 and has held it in 7 quarters since. 14 funds tracked by Wall St. Rank hold AZR as of Q3 2026.

  • Jane Street held 53,952 shares of Azora Therapeutics, Inc. Common Stock worth $216K as of Q3 2026.
  • Jane Street bought 21,833 Azora Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $93.9K.
  • Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9911 holding.
  • Jane Street first reported a position in Azora Therapeutics, Inc. Common Stock in Q1 2019 and has held it in 7 quarters since.
  • 14 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.